RCM
IMMU

RA Capital Management’s Immunomedics Inc IMMU Stock Holding History

RA Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,021,466
Closed -$43.1M – 31
2018
Q4 		$43.1M Sell
3,021,466
-98,312
-3% -$1.95M 2.51% 13
2018
Q3 		$65M Hold
3,119,778
– – 3.47% 10
2018
Q2 		$73.8M Buy
+3,119,778
New +$62.7M 4.79% 6
2017
Q4 		– Sell
-1,478,742
Closed -$20.7M – 33
2017
Q3 		$20.7M Buy
+1,478,742
New +$14.7M 1.87% 16
2014
Q3 		– Sell
-1,000,000
Closed -$3.65M – 51
2014
Q2 		$3.65M Buy
+1,000,000
New +$3.67M 0.37% 25

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RA Capital Management's IMMU Position: Q1 2019 in Review

RA Capital Management sold out of Immunomedics Inc (IMMU) in Q1 2019, closing a stake of 3,021,466 shares — an estimated $43.1M sold.

RA Capital Management first reported a position in IMMU in Q2 2014 and held it in 5 quarters. The position peaked at $73.8M in Q2 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q1 2019.

  • RA Capital Management reported no remaining Immunomedics Inc position as of Q1 2019 after selling out during the quarter.
  • RA Capital Management sold 3,021,466 Immunomedics Inc shares in Q1 2019, an estimated $43.1M.
  • RA Capital Management first reported a position in Immunomedics Inc in Q2 2014 and held it in 5 quarters.
  • RA Capital Management's Immunomedics Inc position peaked at $73.8M in Q2 2018.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2019.

Based on RA Capital Management's 13F filing for Q1 2019, filed 15 May 2019.